Cargando…
Sars-Cov-2 Infection and Vaccination in Recipients of Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide (PTCy)-Based Allogeneic Hematopoietic Cell Transplantation (HCT)
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930029/ http://dx.doi.org/10.1016/S2666-6367(22)00609-1 |
| _version_ | 1784670973219307520 |
|---|---|
| author | Dimitrova, Dimana Sponaugle, Jennifer Bergerson, Jenna R.E. Cohen, Jeffrey I. Freeman, Alexandra F. Notarangelo, Luigi D. Uzel, Gulbu Lisco, Andrea Sereti, Irini Ombrello, Amanda K. Uriarte, Ignacio Campos, Jessenia Chai, Amy Flomerfelt, Francis Kanakry, Jennifer A. |
| author_facet | Dimitrova, Dimana Sponaugle, Jennifer Bergerson, Jenna R.E. Cohen, Jeffrey I. Freeman, Alexandra F. Notarangelo, Luigi D. Uzel, Gulbu Lisco, Andrea Sereti, Irini Ombrello, Amanda K. Uriarte, Ignacio Campos, Jessenia Chai, Amy Flomerfelt, Francis Kanakry, Jennifer A. |
| author_sort | Dimitrova, Dimana |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8930029 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89300292022-03-18 Sars-Cov-2 Infection and Vaccination in Recipients of Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide (PTCy)-Based Allogeneic Hematopoietic Cell Transplantation (HCT) Dimitrova, Dimana Sponaugle, Jennifer Bergerson, Jenna R.E. Cohen, Jeffrey I. Freeman, Alexandra F. Notarangelo, Luigi D. Uzel, Gulbu Lisco, Andrea Sereti, Irini Ombrello, Amanda K. Uriarte, Ignacio Campos, Jessenia Chai, Amy Flomerfelt, Francis Kanakry, Jennifer A. Transplant Cell Ther Poster Session - Immune Reconstitution and Immunobiology American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2022-03 2022-03-18 /pmc/articles/PMC8930029/ http://dx.doi.org/10.1016/S2666-6367(22)00609-1 Text en Copyright © 2022 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Session - Immune Reconstitution and Immunobiology Dimitrova, Dimana Sponaugle, Jennifer Bergerson, Jenna R.E. Cohen, Jeffrey I. Freeman, Alexandra F. Notarangelo, Luigi D. Uzel, Gulbu Lisco, Andrea Sereti, Irini Ombrello, Amanda K. Uriarte, Ignacio Campos, Jessenia Chai, Amy Flomerfelt, Francis Kanakry, Jennifer A. Sars-Cov-2 Infection and Vaccination in Recipients of Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide (PTCy)-Based Allogeneic Hematopoietic Cell Transplantation (HCT) |
| title | Sars-Cov-2 Infection and Vaccination in Recipients of Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide (PTCy)-Based Allogeneic Hematopoietic Cell Transplantation (HCT) |
| title_full | Sars-Cov-2 Infection and Vaccination in Recipients of Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide (PTCy)-Based Allogeneic Hematopoietic Cell Transplantation (HCT) |
| title_fullStr | Sars-Cov-2 Infection and Vaccination in Recipients of Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide (PTCy)-Based Allogeneic Hematopoietic Cell Transplantation (HCT) |
| title_full_unstemmed | Sars-Cov-2 Infection and Vaccination in Recipients of Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide (PTCy)-Based Allogeneic Hematopoietic Cell Transplantation (HCT) |
| title_short | Sars-Cov-2 Infection and Vaccination in Recipients of Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide (PTCy)-Based Allogeneic Hematopoietic Cell Transplantation (HCT) |
| title_sort | sars-cov-2 infection and vaccination in recipients of reduced-intensity conditioning, posttransplantation cyclophosphamide (ptcy)-based allogeneic hematopoietic cell transplantation (hct) |
| topic | Poster Session - Immune Reconstitution and Immunobiology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930029/ http://dx.doi.org/10.1016/S2666-6367(22)00609-1 |
| work_keys_str_mv | AT dimitrovadimana sarscov2infectionandvaccinationinrecipientsofreducedintensityconditioningposttransplantationcyclophosphamideptcybasedallogeneichematopoieticcelltransplantationhct AT sponauglejennifer sarscov2infectionandvaccinationinrecipientsofreducedintensityconditioningposttransplantationcyclophosphamideptcybasedallogeneichematopoieticcelltransplantationhct AT bergersonjennare sarscov2infectionandvaccinationinrecipientsofreducedintensityconditioningposttransplantationcyclophosphamideptcybasedallogeneichematopoieticcelltransplantationhct AT cohenjeffreyi sarscov2infectionandvaccinationinrecipientsofreducedintensityconditioningposttransplantationcyclophosphamideptcybasedallogeneichematopoieticcelltransplantationhct AT freemanalexandraf sarscov2infectionandvaccinationinrecipientsofreducedintensityconditioningposttransplantationcyclophosphamideptcybasedallogeneichematopoieticcelltransplantationhct AT notarangeloluigid sarscov2infectionandvaccinationinrecipientsofreducedintensityconditioningposttransplantationcyclophosphamideptcybasedallogeneichematopoieticcelltransplantationhct AT uzelgulbu sarscov2infectionandvaccinationinrecipientsofreducedintensityconditioningposttransplantationcyclophosphamideptcybasedallogeneichematopoieticcelltransplantationhct AT liscoandrea sarscov2infectionandvaccinationinrecipientsofreducedintensityconditioningposttransplantationcyclophosphamideptcybasedallogeneichematopoieticcelltransplantationhct AT seretiirini sarscov2infectionandvaccinationinrecipientsofreducedintensityconditioningposttransplantationcyclophosphamideptcybasedallogeneichematopoieticcelltransplantationhct AT ombrelloamandak sarscov2infectionandvaccinationinrecipientsofreducedintensityconditioningposttransplantationcyclophosphamideptcybasedallogeneichematopoieticcelltransplantationhct AT uriarteignacio sarscov2infectionandvaccinationinrecipientsofreducedintensityconditioningposttransplantationcyclophosphamideptcybasedallogeneichematopoieticcelltransplantationhct AT camposjessenia sarscov2infectionandvaccinationinrecipientsofreducedintensityconditioningposttransplantationcyclophosphamideptcybasedallogeneichematopoieticcelltransplantationhct AT chaiamy sarscov2infectionandvaccinationinrecipientsofreducedintensityconditioningposttransplantationcyclophosphamideptcybasedallogeneichematopoieticcelltransplantationhct AT flomerfeltfrancis sarscov2infectionandvaccinationinrecipientsofreducedintensityconditioningposttransplantationcyclophosphamideptcybasedallogeneichematopoieticcelltransplantationhct AT kanakryjennifera sarscov2infectionandvaccinationinrecipientsofreducedintensityconditioningposttransplantationcyclophosphamideptcybasedallogeneichematopoieticcelltransplantationhct |